Literature DB >> 28244062

Neutrophilic panniculitis with vasculitis in a melanoma patient treated with vemurafenib: a case report and its management.

Makiko Ueno1, Takeshi Namiki1, Keiko Inui1, Takaaki Hanafusa1, Keiko Miura2, Hiroo Yokozeki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28244062     DOI: 10.1111/ijd.13566

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

Review 1.  Management of the cutaneous adverse effects of antimelanoma therapy.

Authors:  Rose Congwei Liu; Germana Consuegra; Pablo Fernández-Peñas
Journal:  Melanoma Manag       Date:  2017-11-22

2.  Delayed-onset vemurafenib-induced panniculitis.

Authors:  Stephen L Vance; Hannah M Singer; David Silvers; Sameera Husain; Filamer Kabigting
Journal:  JAAD Case Rep       Date:  2017-08-30

Review 3.  Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.

Authors:  Lucie Heinzerling; Thomas K Eigentler; Michael Fluck; Jessica C Hassel; Daniela Heller-Schenck; Jan Leipe; Matthias Pauschinger; Arndt Vogel; Lisa Zimmer; Ralf Gutzmer
Journal:  ESMO Open       Date:  2019-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.